French private equity firm Ardian has agreed to acquire a minority stake in IVB Wellness Lab, a Spanish supplements brand. The deal signals growing investor interest in the health and wellness sector, particularly in established European consumer brands. While financial terms remain undisclosed, the move represents a strategic entry into the VMS market—vitamins, minerals, and supplements—during a period of active dealmaking.

Spain’s consumer health market has matured significantly over the past decade, driven by an aging population and increased focus on preventative care. Private equity firms like Ardian are increasingly targeting resilient consumer sectors that offer steady cash flows and growth potential independent of broader economic cycles. IVB Wellness Lab fits this profile as an established player in a defensive industry.

This acquisition aligns with Ardian’s broader strategy of investing in mid-market companies with strong regional footprints. For IVB, the partnership provides capital for expansion and operational expertise from a global investor. The deal closes as other PE firms pivot toward defensive assets, balancing riskier bets in volatile markets with steady consumer healthcare investments.